Company page

Lipocine Inc.

Lipocine Inc. (ticker: LPCN) is a public company based in the United States, with a market capitalization of approximately $18.6 million. The company focuses on developing innovative pharmaceutical products, particularly in the field of hormone therapy. Lipocine aims to address unmet medical needs through its proprietary drug delivery technologies.